Short-term Perfusion Angiography Pilot Study (SPA)



Status:Recruiting
Conditions:Peripheral Vascular Disease
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:5/13/2018
Start Date:January 2017
End Date:March 2019
Contact:Ami Sood, M.D.
Email:asood@volcanocorp.com

Use our guide to learn which trials are right for you!

Short-term 2D Perfusion Angiography Pilot Study

The Short term Perfusion Angiography (SPA) study is designed to collect 2D Perfusion data
from Critical Limb Ischemia (CLI) endovascular (interventional) procedures for information on
device performance in a real-world setting.

This clinical study is designed to collect pre and post procedural imaging data using 2D
Perfusion (2DP) software in patients receiving an endovascular intervention.

Inclusion Criteria:

1. Subject is ≥ 18 years of age.

2. Subject or their legally authorized representative understands the research nature of
the study and is willing and capable of providing informed consent

3. Subject has appropriate femoral arterial access

4. Subject presents with a Rutherford classification of 4 to 6.

5. Planned DSA with endovascular intervention below the knee on one or both limbs. This
may include patients who undergo:

1. Above the knee (ATK) and below the knee (BTK) intervention during the same
procedure.

2. Only BTK intervention.

3. ATK intervention with staged future BTK intervention within 6 weeks of the
initial procedure.

Exclusion Criteria:

1. Subjects whose ATK intervention is limited to only the common femoral or iliac
arteries

2. Subject is unwilling or unable to comply with the protocol including all follow-up
visits

3. Subject with active atrial fibrillation at time of procedure

4. Critical limb ischemia due to acute arterial occlusion.

5. Subject with documented ejection fraction < 40% and/or prolonged bradycardia (< 60
beats per minute)

6. Inability to collect toe pressure on index limb from subject

7. Subjects with history of or known reaction or sensitivity to contrast agent that
cannot be pre-medicated or any other condition that precludes an endovascular
intervention and DSA

8. Female subject of childbearing potential who is pregnant (she must have negative
pregnancy test within the 48 hours prior to enrollment), or plans a pregnancy during
study period,

9. Subject life expectancy < 3 months,

10. Subject is participating in a potentially confounding device or drug clinical trial
that interferes with this study

11. Investigator considers subject to be a poor candidate for the study or believes that
the patient may compromise the study, e.g., concomitant conditions (reasons will be
documented) )
We found this trial at
4
sites
Raleigh, North Carolina 27607
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
Cleveland, Ohio 44106
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
5900 Byron Center Ave SW
Wyoming, Michigan 49519
(616) 252-7200
Metro Health Hospital Metro Health is an integrated healthcare system offering expert, award-winning care that
?
mi
from
Wyoming, MI
Click here to add this to my saved trials